Status and phase
Conditions
Treatments
About
The purpose of this study is to find out whether a biopsy technique called transbronchial cryobiopsy (TBCB) is a safe alternative to the standard biopsy procedure (transbronchial forceps biopsy; TBFB). The study researchers think that TBCB may provide better biopsy samples to help diagnose lung disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients with pulse oximetry less than 92% on oxygen delivery up to 2 L nasal cannula.
Uncorrectable coagulopathy defined as:
Known pulmonary hypertension or echocardiographic pulmonary artery systolic pressure >50mmHg
A secure diagnosis based on clinical and high-resolution CT scan data.
Antiplatelet therapy that cannot be held for more than 5 days.
Any patient deemed unfit to undergo bronchoscopy by the proceduralist
Female patients with a positive pregnancy test within 30 days of the planned study procedure
Primary purpose
Allocation
Interventional model
Masking
100 participants in 1 patient group
Loading...
Central trial contact
Mohit Chawla, MD; Bryan Husta, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal